Berger Franklin M's Form 4/A amendment
AmendedAtea Pharmaceuticals, Inc. (AVIR) · filed Jan 17, 2025
- Accession no.
- 0000950170-25-006589
- Filed
- Jan 17, 2025
- Trade date
- Jan 15-16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jan 17, 2025
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $81.5K. It was filed 2 days after the trade.
This amendment replaces 0000950170-25-006489 (filed Jan 17, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berger Franklin MCIK 0001273885 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | Common Stock | PPurchaseAcquired | +15,000 | $3.19 | +$47,850 | 466,897 | Direct | |
| Jan 16, 2025 | Common Stock | PPurchaseAcquired | +10,000 | $3.36 | +$33,600 | 476,897 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.